USA - New York Stock Exchange - NYSE:PBH - US74112D1019 - Common Stock
ChartMill assigns a Buy % Consensus number of 84% to PBH. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-07 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-10-27 | Jefferies | Maintains | Hold -> Hold |
| 2025-10-21 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-08-08 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-03-21 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-02-13 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-02-07 | DA Davidson | Maintains | Buy -> Buy |
| 2025-02-07 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-11-11 | DA Davidson | Maintains | Buy -> Buy |
| 2024-08-28 | DA Davidson | Maintains | Buy -> Buy |
| 2024-08-09 | DA Davidson | Maintains | Buy -> Buy |
| 2024-06-21 | DA Davidson | Upgrade | Neutral -> Buy |
| 2024-05-21 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-05-16 | DA Davidson | Maintains | Neutral -> Neutral |
| 2023-06-26 | DA Davidson | Reiterate | Neutral -> Neutral |
| 2023-05-08 | DA Davidson | Reiterate | Neutral |
| 2023-03-17 | RBC Capital | Maintains | Sector Perform |
| 2023-02-17 | Oppenheimer | Maintains | Outperform |
| 2023-01-13 | Oppenheimer | Maintains | Outperform |
| 2022-11-17 | Canaccord Genuity | Initiate | Buy |
| 2022-05-10 | Jefferies | Upgrade | Hold -> Buy |
| 2022-05-09 | DA Davidson | Maintains | Neutral |
| 2022-05-09 | Oppenheimer | Upgrade | Perform -> Outperform |
| 2022-03-11 | BMO Capital | Maintains | Outperform |
| 2021-11-15 | DA Davidson | Maintains | Neutral |
| 2021-08-06 | DA Davidson | Maintains | Neutral |
| 2021-05-28 | DA Davidson | Maintains | Neutral |
| 2021-05-10 | DA Davidson | Maintains | Neutral |
10 analysts have analysed PBH and the average price target is 79.05 USD. This implies a price increase of 31.07% is expected in the next year compared to the current price of 60.31.
The consensus rating for PRESTIGE CONSUMER HEALTHCARE (PBH) is 84 / 100 . This indicates that analysts generally have a positive outlook on the stock.